Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$506M |
| 2 |
Microsoft
MSFT
|
+$355M |
| 3 |
ExxonMobil
XOM
|
+$267M |
| 4 |
Amazon
AMZN
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$245M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$86.2M |
| 2 |
Suncor Energy
SU
|
+$80.1M |
| 3 |
SE
Spectra Energy Corp Wi
SE
|
+$79.6M |
| 4 |
STJ
St Jude Medical
STJ
|
+$63.5M |
| 5 |
TC Energy
TRP
|
+$59.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Healthcare | 15% |
| 3 | Consumer Discretionary | 10.63% |
| 4 | Communication Services | 10.48% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Emcor
EME
$35.7B
| $6.29M | 0.01% |
99,900
| – | – |
|
852
Bio-Techne
TECH
$11.2B
| $6.27M | 0.01% |
246,844
+1,600
| +0.7% | +$41.3K |
|
|
DST
853
DELISTED
DST Systems Inc.
DST
| $6.27M | 0.01% |
102,400
+800
| +0.8% | +$46.4K |
|
854
Hancock Whitney
HWC
$6.23B
| $6.27M | 0.01% |
137,600
+1,100
| +0.8% | +$50.2K |
|
|
NATI
855
DELISTED
National Instruments Corp
NATI
| $6.24M | 0.01% |
191,700
+1,500
| +0.8% | +$47.7K |
|
|
AL
856
DELISTED
Air Lease Corp
AL
| $6.23M | 0.01% |
160,800
+1,600
| +1% | +$60.2K |
|
857
Woodward
WWD
$21B
| $6.23M | 0.01% |
91,700
+700
| +0.8% | +$48.4K |
|
|
HR
858
DELISTED
Healthcare Realty Trust Incorporated
HR
| $6.23M | 0.01% |
191,600
+1,200
| +0.6% | +$37.1K |
|
859
Neurocrine Biosciences
NBIX
$16.8B
| $6.22M | 0.01% |
143,600
+1,000
| +0.7% | +$42.8K |
|
860
Primerica
PRI
$9.65B
| $6.21M | 0.01% |
75,500
-1,000
| -1% | -$78K |
|
|
TARO
861
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6.2M | 0.01% |
53,200
-3,800
| -7% | -$421K |
|
|
NUVA
862
DELISTED
NuVasive, Inc.
NUVA
| $6.2M | 0.01% |
83,069
+600
| +0.7% | +$43.5K |
|
863
The GEO Group
GEO
$4.04B
| $6.2M | 0.01% |
200,400
+18,300
| +10% | +$526K |
|
|
DFT
864
DELISTED
DuPont Fabros Technology Inc.
DFT
| $6.16M | 0.01% |
124,240
| – | – |
|
|
EQC
865
DELISTED
Equity Commonwealth
EQC
| $6.16M | 0.01% |
197,300
+1,200
| +0.6% | +$37.2K |
|
866
Cabot Corp
CBT
$4.46B
| $6.14M | 0.01% |
102,500
| – | – |
|
867
Manhattan Associates
MANH
$11.4B
| $6.13M | 0.01% |
117,720
| – | – |
|
868
Nabors Industries
NBR
$1.33B
| $6.13M | 0.01% |
9,375
+58
| +0.6% | +$44.4K |
|
|
GPT
869
DELISTED
Gramercy Property Trust
GPT
| $6.12M | 0.01% |
232,684
+1,500
| +0.6% | +$40.3K |
|
870
MKS Inc
MKSI
$19.8B
| $6.1M | 0.01% |
88,700
+600
| +0.7% | +$39.5K |
|
871
Madison Square Garden
MSGS
$9.43B
| $6.1M | 0.01% |
42,807
+280
| +0.7% | +$36.4K |
|
|
CST
872
DELISTED
CST Brands, Inc.
CST
| $6.1M | 0.01% |
126,800
| – | – |
|
873
CoreCivic
CXW
$3.26B
| $6.09M | 0.01% |
193,718
+1,200
| +0.6% | +$36.7K |
|
|
BLUE
874
DELISTED
bluebird bio
BLUE
| $6.07M | 0.01% |
5,158
| – | – |
|
875
Wipro
WIT
$19.7B
| $6.07M | 0.01% |
3,163,237
| – | – |
|
Similar funds
Swiss National Bank's Q1 2017 Portfolio in Review
As of Q1 2017, Swiss National Bank held 2,570 positions worth $80.4B, up 27% from $63.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Swiss National Bank deployed $13.1B of net new capital in Q1 2017, opening 6 new positions and adding to 1,330 existing holdings. Its largest new stake was Qiagen: 988,583 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Canadian National Railway, an estimated $86.2M trimmed.
- Swiss National Bank's largest Q1 2017 buy was Qiagen: 988,583 shares worth $30.5M.
- Swiss National Bank added most to Apple in Q1 2017, an estimated $506M increase.
- Swiss National Bank's biggest Q1 2017 reduction was Canadian National Railway, cutting an estimated $86.2M.
- Swiss National Bank fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $79.6M.
- Swiss National Bank's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2017.
- Swiss National Bank opened 6 new positions and closed 36 in Q1 2017.
- Swiss National Bank's portfolio value rose 27% quarter-over-quarter to $80.4B.
Based on Swiss National Bank's 13F filing for Q1 2017, filed 4 May 2017.